Dengue fever management in hospital im a doctor and give me the infusion medication chart for 43 yr old ot
Associated with hb 9.1
Fatigue, generalized weekness cough
WHO dengue management guidelines 2024 fluid therapy intravenous chart Group B Group C
| Test | Target/Purpose |
|---|---|
| FBC (CBC) | Hb baseline, HCT, platelet count |
| Serum HCT (repeat 4-6 hourly) | Guide fluid titration |
| Blood group & type | Hb 9.1 - anticipate transfusion need |
| LFT, RFT, blood glucose | Organ involvement |
| NS1 Ag, IgM/IgG dengue serology | Confirm diagnosis |
| CXR / USS abdomen | Pleural effusion, ascites |
| Urine output chart | Target: 0.5 mL/kg/h (~35 mL/h) |
Note: For adults, PAHO/WHO brackets adult rates in fixed mL/h. Use ideal body weight for obese patients.
| Phase | Duration | Rate (mL/kg/h) | Rate for 70 kg (mL/h) | Drip Rate (drops/min)* |
|---|---|---|---|---|
| Initial loading | First 1-2 h | 5-7 mL/kg/h | 350-490 mL/h | ~87-122 drops/min |
| Step down 1 | Next 2-4 h | 3-5 mL/kg/h | 210-350 mL/h | ~52-87 drops/min |
| Step down 2 | Next 2-4 h | 2-3 mL/kg/h | 140-210 mL/h | ~35-52 drops/min |
| Maintenance | Till oral tolerated (24-48 h total) | 1.5-2 mL/kg/h | 105-140 mL/h | ~26-35 drops/min |
Re-assess after EVERY phase. Increase/decrease rate based on HCT trend and clinical response.
| Finding | Action |
|---|---|
| HCT rising ≥ 10-20% from baseline | Increase IV fluid rate to next higher step |
| HCT falling + good pulse volume | Reduce or stop IV fluids |
| Urine output < 0.5 mL/kg/h | Increase rate |
| Urine output > 1 mL/kg/h | Reduce rate (prevent fluid overload) |
| BP stable + apyrexial >24-48 h | Step down to oral, discontinue IV |
| Signs of fluid overload (crepitations, effusion, distension) | Reduce rate aggressively |
| Drug | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Paracetamol (antipyretic) | 500-1000 mg | PO / IV | Every 6 hours PRN | While febrile |
| Ondansetron (antiemetic) | 4-8 mg | IV slow | Every 8 h PRN | If vomiting |
| Pantoprazole (GI protection) | 40 mg | IV | Once daily | During admission |
| Oral rehydration (ORS) | 500 mL | PO | Every 2-4 h | If tolerating orally |
AVOID: NSAIDs (aspirin, ibuprofen, diclofenac), IM injections, corticosteroids.
| Scenario | Action |
|---|---|
| Hb 9.1, haemodynamically stable, no active bleeding | Monitor closely - do NOT transfuse unless Hb drops or active haemorrhage |
| Hb drops < 7 g/dL or haemodynamic compromise | 1 unit PRBC (Packed Red Blood Cells) - transfuse slowly over 3-4 h, check post-transfusion Hb |
| Platelet < 20,000/µL + active bleeding | Single donor platelets (SDP) or random donor platelets (RDP) |
| Platelet < 10,000/µL (prophylactic, no bleeding) | Discuss transfusion - most guidelines defer unless clinical deterioration |
Key point: Hb 9.1 with dengue - check if this is pre-existing anaemia vs dengue-related haemolysis. A peripheral smear helps.
| Action |
|---|
| CXR - check for pleural effusion or consolidation |
| SpO2 monitoring |
| If effusion confirmed: do NOT tap unless causing respiratory distress (SpO2 < 94%) |
| Cough suppressant (e.g., dextromethorphan) if dry non-productive cough only |
| If consolidation/infection suspected: consider antibiotic (Amoxicillin or Azithromycin) |
Disclaimer: This chart follows WHO/PAHO Dengue Guidelines. Titrate all fluids based on real-time HCT, urine output, and haemodynamic status. The anaemia (Hb 9.1) warrants close monitoring - confirm whether pre-existing or dengue-related before planning transfusion.
Can we add antibiotics it can helps
dengue fever antibiotic coinfection bacterial